Loading...

Savara Inc.

SVRA•NASDAQ
Healthcare
Biotechnology
$5.87
$-0.20(-3.29%)
U.S. Market opens in 16h 37m

Savara Inc. (SVRA) Stock Overview

Explore Savara Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-11.46
EPS (TTM)$-0.53
ROE-0.84%
Fundamental Analysis

AI Price Forecasts

1 Month$5.53
3 Months$7.77
1 Year Target$4.98

SVRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Savara Inc. (SVRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.05, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.98.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.46 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.29%
5-Day Change
N/A
1-Month Change
11.81%
3-Month Change
-0.17%
6-Month Change
63.06%
Year-to-Date (YTD) Change
-2.65%
1-Year Change
100.34%
3-Year Change
233.52%
5-Year Change
249.40%
All-Time (Max) Change
-32.99%

Contact Information

https://www.savarapharma.com
512 614 1848
Building III, Langhorne, TX, 78746

Company Facts

59 Employees
IPO DateApr 28, 2017
CountryUS
Actively Trading

Frequently Asked Questions